Another rheumatoid arthritis model in mice using BAFFR siRNA-coated nanoparticles targeted to deliver B cells after intravenous injection reduced arthritis scores, serum anti-collagen IgG levels, and improved rheumatoid arthritis symptoms in collagen induced arthritis (CIA) mouse models (32). This evidence concerns the gene TNFRSF13C and arthritic joint disease.